CDTX vs WFC · rev $1.3M vs P/E 15, $272.05B cap
Cidara Therapeutics Inc (CDTX) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
WFC does not have a complete income-statement cache yet.
CDTX currently screens at market cap $6.96B. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the CDTX and WFC stock pages for the full models.
Not investment advice.